This revised application is being submitted to obtain funding for the Cleveland Digestive Diseases Research Core Center (DDRCC), which is a combined effort between Case Western Reserve University (CWRU) and the Cleveland Clinic Foundation (CCF). The Cleveland DDRCC is a cross-institutional and multi-disciplinary program, including 34 full members and 18 associate members from 15 different academic departments. The Center's two major themes are Digestive Inflammation and Metabolism, both of which represent well established areas of collaborative investigation at CWRU and the CCF. The proposed Cleveland DDRCC will: 1) enhance the basic research capabilities of Center investigators, 2) develop and implement programs to support the independent development of young investigators in Digestive Inflammation and Metabolism research, 3) attract established investigators with varied expertise who are not currently involved in digestive disease research to apply their expertise to this important area of investigation, and 4) facilitate the translationof basic research discoveries to the clinical arena. We have strong institutional support, including an initial investment of $1.3 million to increase the impact of digestive disease research at both institutions. The Research Base for the Center consists of $15 0 million in federal grants (48 NIH, 1 DOD, 1 VA, 1 NSF) specifically related to Digestive Inflammation and Metabolism, with 5 1% of these funds coming directly from the NIDDK ($7.6 million). We are proposing 3 scientific cores to support this strong Research Base: 1) BioRepository Core, 2) Histology/Imaging Core, and 3) Mouse Models Core. These core laboratories interface with a well-organized Administrative Core, which also supports Pilot/Feasibility and Named New Investigator Programs to promote innovative research projects by investigators who are new to the area of digestive diseases. The Administrative Core also includes an Enrichment Program and a Clinical Component, and oversees the financial management and operation of the Cleveland DDRCC. The overall objective of the Cleveland DDRCC is to increase the availability of core resources for Center members, and foster research, collaborations, and new directions in digestive disease research.

Public Health Relevance

The Cleveland DDRCC is focused on the pathogenic mechanisms of Digestive Inflammation and Metabolism (i.e., IBD, hepatitis, metabolic syndromes, and obesity), which affect millions of people in the US. By providing state-of-the-art services to DDRCC investigators at two major institutions, the Center will foster multi-disciplinary and collaborative research that will lead to new discoveries and treatments, thus having a large impact on the health of patients suffering from digestive diseases.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M2))
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Mehta, Kathan; Jaiswal, Palashkumar; Briggs, Farren et al. (2018) In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study. Sci Rep 8:6825
Liu, Zhonghua; Wang, Chuanping; Rathkey, Joseph K et al. (2018) Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition. Structure 26:778-784.e3
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Perez, Jessica M; Chen, Yinghua; Xiao, Tsan S et al. (2018) Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase. J Biol Chem 293:1100-1105
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Rodriguez-Palacios, Alexander; Aladyshkina, Natalia; Ezeji, Jessica C et al. (2018) 'Cyclical Bias' in Microbiome Research Revealed by A Portable Germ-Free Housing System Using Nested Isolation. Sci Rep 8:3801
Rieder, F; Bettenworth, D; Ma, C et al. (2018) An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther 48:347-357
Chan, M Q; Blum, A E; Chandar, A K et al. (2018) Association of sporadic and familial Barrett's esophagus with breast cancer. Dis Esophagus 31:
Cummings III, Kenneth C; Zimmerman, Nicole M; Maheshwari, Kamal et al. (2018) Epidural compared with non-epidural analgesia and cardiopulmonary complications after colectomy: A retrospective cohort study of 20,880 patients using a national quality database. J Clin Anesth 47:12-18

Showing the most recent 10 out of 86 publications